Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

  • Vigón, Lorena
  • Vázquez-Morón, Sonia|||0000-0002-0977-741X
  • Berenguer, Juan|||0000-0001-8541-8200
  • González García, Juan|||0000-0002-3652-002X
  • Jiménez-Sousa, Ma Ángeles
  • Guardiola Tey, Jose Maria|||0000-0001-5537-2600
  • Crespo Casal, Manuel|||0000-0001-9016-0515
  • de los Santos Gil, Ignacio|||0000-0001-7073-5211
  • Von Wichmann, Miguel Ángel
  • Carrero, Ana
  • Yélamos, María Belén
  • Gómez, Julián
  • Resino, Salvador|||0000-0001-8783-0450
  • Martínez, Isidoro|||0000-0002-9949-9264
  • Miralles, Pilar
  • López, Juan Carlos
  • Parras, Francisco José
  • Padilla Ortega, Belén
  • Aldámiz-Echevarría Lois, Maria Teresa|||0000-0002-4374-6940
  • Tejerina, Francisco|||0000-0002-4136-3575
  • Diez, Cristina
  • Pérez Latorre, Leire|||0000-0001-9919-3778
  • Fanciulli, Chiara|||0000-0003-2175-9027
  • Gutiérrez, Isabel
  • Ramírez, Manuel|||0000-0003-0332-6973
  • Carretero, S.
  • Bellón, José-María|||0000-0002-8492-1565
  • Bermejo, Javier|||0000-0002-5241-2758
  • Hontañón Antoñana, Víctor|||0000-0003-3070-2647
  • Arribas, Jose|||0000-0002-7410-9450
  • Montes, María Luisa|||0000-0003-1748-813X
  • Bernardino, José Ignacio|||0000-0003-3501-8529
  • Pascual Pareja, J. Francisco
  • Zamora, Francisco
  • Peña, Jose M.
  • Arnalich Fernandez, Francisco|||0000-0003-2943-0373
  • Díaz, Marta
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Sanz, Jaime|||0000-0001-6934-4619
  • Bustinduy, M.J.
  • Iribarren, José Antonio
  • Rodríguez-Arrondo, F.
  • Eynde, E.Van den
  • Pérez, M.
  • Ribera, E.
  • Casado, José Luis|||0000-0002-7639-8591
  • Dronda, Fernando|||0000-0002-0443-5816
  • Moreno, A.
  • Pérez Elías, Mª Jesus|||0000-0001-5700-5257
  • Sanfrutos, M.A.
  • Moreno, S.
  • Quereda, Carmen
  • Arranz, A.
  • Casas Díaz, Encarna|||0000-0002-5901-6555
  • Miguel, J.de
  • Schroeder, S.
  • Vergas, J.
  • Téllez, M.J.
  • Vinuesa, D.
  • Muñoz, Lourdes
  • Hernández Quero, José
  • Ferrer, A.
  • Galindo Puerto, María José
  • Ortiz, L.
  • Ortega, Emilio|||0000-0002-2217-8905
  • Montero, M.
  • Blanes, M.
  • Cuellar, S.
  • Lacruz, José
  • Salavert, Miguel|||0000-0002-8571-2124
  • López-Aldeguer, J.
  • Pérez González, Gustavo|||0000-0001-9112-9042
  • Gaspar, G.
  • Yllescas, M.
  • Crespo, P.
  • Aznar, E.
  • Esteban, H.
The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-IFNα + ribavirin anti-HCV therapy. Plasma samples at baseline and week 24 after SVR were used to perform neutralization assays against five JFH1-based HCV recombinant viruses coding for E1 and E2 from genotypes 1a (H77), 1b (J4), 2a (JFH1), 3a (S52) and 4a (ED43). At baseline, the majority of plasma samples neutralized 1a, 1b, 2a, and 4a, but not 3a, genotypes. Twenty-four weeks following SVR, most neutralizing titers declined substantially. Furthermore, titers against 3a and 2a were not detected in many patients. Plasma samples with high HCV-nAb titers neutralized all genotypes, and the highest titers at the starting point correlated with the highest titers at week 24 after SVR. In conclusion, high titers of broad-spectrum HCV-nAbs were detected in HIV/HCV-coinfected individuals, however, those titers declined soon after SVR.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014)

  • Vázquez-Morón, Sonia|||0000-0002-0977-741X
  • Berenguer, Juan|||0000-0001-8541-8200
  • González García, Juan|||0000-0002-3652-002X
  • Jiménez-Sousa, Ma Ángeles
  • Canorea, Isabel
  • Guardiola Tey, Jose Maria|||0000-0001-5537-2600
  • Crespo Casal, Manuel|||0000-0001-9016-0515
  • Quereda, Carmen
  • Sanz, José
  • Carrero, Ana
  • Hontañón Antoñana, Víctor|||0000-0003-3070-2647
  • Avellón, Ana|||0000-0003-4425-6350
  • Resino, Salvador|||0000-0001-8783-0450
Hepatitis E virus (HEV) has emerged as a relevant pathogen for HIV-infected patients. However, there is scarce data on HEV infection in HIV/HCV-coinfected individuals with advanced fibrosis, which seems to increase the risk of HEV infection and worsen the prognosis of liver disease. We aimed to determine the prevalence of anti-HEV antibodies, acute hepatitis E, resolved hepatitis E, and exposure to HEV in HIV/HCV-coinfected patients and to evaluate associations with clinical and epidemiological characteristics. We performed a cross-sectional study on 198 HIV/HCV-coinfected patients, 30 healthy controls and 36 HIV-monoinfected patients. We found a low concordance between techniques used for detection of anti-HEV antibodies (ELISA versus Immunoblot), particularly in HIV/HCV-coinfected patients. HIV/HCV-coinfected patients showed the highest prevalence of IgG against HEV, resolved hepatitis E, and exposure to HEV (19.2%, 17.2%, and 22.2% respectively). However, we did not find any samples positive for HEV-RNA nor significant differences between groups. Moreover, HIV/HCV-coinfected patients with CD4 T-cells <350 cells/mm had higher prevalence for anti-HEV IgG antibodies, resolved hepatitis E, and exposure to HEV than healthy controls or those with CD4 T-cells ≥ 350 cells/mm (p = 0.034, p = 0.035, and p = 0.053; respectively). In conclusion, HIV/HCV-coinfected patients in Spain have a high prevalence for IgG anti-HEV antibodies, resolved hepatitis E, and exposure to HEV; particularly patients with CD4+T-cells <350 cells/mm.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human immunodeficiency virus/hepatitis C virus coinfection in Spain, Prevalence and patient characteristics

  • Berenguer, Juan|||0000-0001-8541-8200
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • Jarrín, Inma|||0000-0002-7485-2252
  • Núñez, María José
  • Vivancos-Gallego, María J.|||0000-0002-9373-6011
  • Crespo Casal, Manuel|||0000-0001-9016-0515
  • Téllez, María Jesús
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Iribarren, José Antonio
  • Artero, Arturo|||0000-0002-7479-3408
  • Márquez, Manuel
  • Santos, Ignacio
  • Moreno, Javier
  • Montero, Marta|||0000-0002-3432-5394
  • González García, Juan|||0000-0002-3652-002X
  • Pérez Latorre, Leire|||0000-0001-9919-3778
  • Miralles, Pilar
  • Lopez-Gutierrez, Juan Carlos|||0000-0003-0445-6796
  • Parras, Francisco José
  • Padilla Ortega, Belén
  • Aldámiz-Echevarría Lois, Maria Teresa|||0000-0002-4374-6940
  • Carrero, Ana
  • Diez, Cristina
  • Tejerina, Francisco|||0000-0002-4136-3575
  • Arnalich Fernandez, Francisco|||0000-0003-2943-0373
  • Arribas, Jose|||0000-0002-7410-9450
  • Bernardino, José Ignacio|||0000-0003-3501-8529
  • Hontañón Antoñana, Víctor|||0000-0003-3070-2647
  • Martín Carbonero, Luz|||0000-0001-8102-4079
  • Montejano Sanchez, Rocio|||0000-0002-3446-0545
  • Montes, María Luisa|||0000-0003-1748-813X
  • Moreno, Victoria
  • Pérez Valero, Ignacio|||0000-0002-3488-7135
  • Navarro, Carolina
  • Valencia, Eulalia|||0000-0001-6902-0120
  • Cuenca, Francisca
  • Rivero-Román, Antonio
  • Moreno, Santiago C.
  • Moreno, Ana
  • Casado, José Luis|||0000-0002-7639-8591
  • Pérez-Elías, M.J.
  • Quereda, Carmen
  • Torrella Domingo, Adriana|||0000-0003-1848-5096
  • Navarro, Jordi|||0000-0002-7187-0367
  • Ramos, Nuria
  • Ròdrigo, María José
  • Estrada, Vicente|||0000-0002-7795-5986
  • Vergas, Jorge
  • Muñoz, Jessica
  • Gutiérrez Hernández, Maria del Mar|||0000-0001-6215-6412
  • Mateo, María Gracia|||0000-0003-1389-9310
  • Guardiola Tey, Jose Maria|||0000-0001-5537-2600
  • Ibarguren, Maialen
  • Carmona, María Pilar
  • Rodríguez-Arrondo, Francisco J.
  • Goenaga, Miguel Ángel
  • Azkune, Harkaitz
  • Von Wichmann, Miguel Ángel
  • Carmena, Jorge
  • Ruiz, Josefa
  • Nuño, Enrique
  • Palacios, Rosario
  • Santos, Jésus R.
  • Sanz, Jesús M.
  • Arazo, Piedad
  • Tasias, Maria
  • Cuellar, Sandra
  • Calabuig, Eva|||0000-0002-0177-0037
  • Blanes, Marino
  • Fernández, Juan Manuel R.
  • López-Aldeguer, José
  • Salavert, Miguel|||0000-0002-8571-2124
  • Hernando, Asunción|||0000-0002-1901-1119
  • Domínguez-Domínguez, Lourdes|||0000-0001-6018-9026
  • Bisbal, Otilia|||0000-0003-3746-3378
  • De Lagarde, Maria
  • Matarranz, Mariano
  • Rubio García, Rafael|||0000-0001-8132-4303
  • Pulido, Federico|||0000-0002-7414-8812
  • García, Coral
  • Armiñanzas-Castillo, Carlos
  • Echevarría, Santiago
  • Gutiérrez-Cuadra, Manuel
  • Fariñas, Carmen
  • Giner, Livia|||0000-0002-1885-3736
  • Reus, Sergio|||0000-0002-3320-9754
  • Merino de Lucas, Esperanza|||0000-0003-3854-4874
  • Boix, Vicente|||0000-0002-7015-3948
  • Torrús-Tendero, Diego
  • Portilla-Tamarit, Irene
  • Pampliega, Maria
  • Díez, Marcos
  • Egea, I.
  • Portilla, Joaquín|||0000-0002-3676-9511
  • Ferrero, Óscar Luis
  • Ibarra, Sofía E.
  • López, Iñigo
  • De La Peña, Mireia
  • Zubero, Zurinẽ
  • Baraia-Etxaburu, Josu
  • Muñoz, Josefa J.
  • de Miguel, Julio
  • Arranz-Caso, Alberto J.
  • Casas, Esperanza
  • Sanz, Jose N.
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Galindo Puerto, María José
  • García, Luis Nm
  • Pérez, Laura
  • Oteo, José A.|||0000-0001-7080-6542
  • Velasco Arribas, Maria|||0000-0001-6554-2095
  • Moreno Núñez, Leonor
  • Hervás, Rafael
  • Losa-García, Juan Emilio
  • Vinuesa, David|||0000-0002-5663-8447
  • Muñoz Medina, Leopoldo|||0000-0001-8995-8271
  • Hernández Quero, José
  • Veloso Esteban, Sergio|||0000-0001-7943-1169
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • Castellano, Alfonso J.
  • Vidal, Francesc|||0000-0002-6692-6186
  • Silvariño, Rafael
  • Orti, Amat Joaquim
  • Chamarro, Elena
  • Escrig, Cristina
  • Geijo, Paloma
  • Chocarro, Ángel
  • Rodríguez, Carmen
  • Puerta, Teresa
  • Raposo, Montserrat
  • Vera, Mar|||0000-0002-3841-7747
  • Del Romero, Jorge
  • Bisbe, Josep
  • Cifuentes, Carmen|||0000-0001-5521-4573
  • Teira, Ramon|||0000-0002-0172-564X
  • Vilaró, Josep M.
  • Vegas, Ana
  • Cano, Alfredo
  • Alcaraz García, Antonia
  • Muñoz, Ángeles
  • Bernal, Enrique|||0000-0002-4041-0579
  • Campoamor, M. T.
  • Tuya, Maria José
  • de la Fuente, Balén
  • de Ardoz, T.
  • Gimeno Gascon, Adelina|||0000-0003-3728-3182
  • Montero, Carmen
  • Arponen, Sari
  • Force, Lluís
  • Barrufet Barqué, Pilar
  • Gaspar Alonso-Vega, Gabriel|||0000-0002-7144-8959
  • Alonso, Gerardo
  • Toledo, Claudio
  • Peláez-Ballesta, Ana Isabel
  • Lara, G.
  • Fernandez, Irene
  • Esteban, Mariano|||0000-0003-0846-2827
The purpose of this study was to assess the prevalence of anti-hepatitis C virus (HCV) antibodies (Abs) and active HCV infection in human immunodeficiency virus (HIV)-infected (HIV+) patients in Spain in 2015. This was a cross-sectional study.Methods. The study was performed in 41 centers in 2015. Sample size was estimated for an accuracy of 2%, the number of patients from each hospital was determined by proportional allocation, and patients were selected using simple random sampling. The reference population was 35 791 patients, and the sample size was 1867 patients. Hepatitis C virus serostatus was known in 1843 patients (98.7%). Hepatitis C virus-Abs were detected in 695 patients (37.7%), in whom the main route of HIV acquisition was injection drug use (75.4%). Of these 695 patients, 402 had HCV RNA, 170 had had a sustained viral response (SVR) after anti-HCV therapy, and 102 cleared HCV spontaneously. Hepatitis C virus-ribonucleic acid results were unknown in 21 cases. Genotype distribution (known in 367 patients) was 1a in 143 patients (39.0%), 4 in 90 (24.5%) patients, 1b in 69 (18.8%) patients, 3 in 57 (15.5%) patients, 2 in 5 (1.4%) patients, and mixed in 3 (0.8%) patients. Liver cirrhosis was present in 93 patients (23.1%) with active HCV infection and in 39 (22.9%) patients with SVR after anti-HCV therapy. The prevalence of HCV-Abs and active HCV infection in HIV+ patients in Spain is 37.7% and 22.1%, respectively; these figures are significantly lower than those recorded in 2002 and 2009. The predominant genotypes in patients with active HCV infection were 1a and 4. A high percentage of patients had cirrhosis. Cirrhosis is also common in patients with SVR after anti-HCV therapy.